UC-764864
Based on 1 Customer Validation
UC-764864 is a selective UBE2N inhibitor. UC-764864 covalently binds UBE2N catalytic Cys87, blocks ubiquitin-UBE2N thioester formation and polyubiquitin chain synthesis. UC-764864 blocks ubiquitination of innate immune- and inflammatory-related substrates, and induces cell apoptosis. UC-764864 can be used for the research of acute myeloid leukemia.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 99.89%
- CAS 番号: 278806-03-4
- 分子式: C19H18N2OS
- 分子量:322.42
-
保管条件:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
生物活性
製品説明
体外実験
UC-764864 (1-10 μM) potently and selectively inhibits wild-type UBE2N catalytic activity via its Cys87 residue[1].
UC-764864 (1 nM-0.1 mM; 1 h) selectively binds to the catalytic Cys87 residue of UBE2N in human MOLM-13 AML cells[1].
UC-764864 (2 μM; 24 h) selectively reduces UBE2N autoubiquitination at Lys92 and disrupts UBE2N-dependent innate immune and inflammatory signaling pathways in human MOLM-13 AML cells[1].
UC-764864 (1 nM-0.1 mM) potently and selectively inhibits UBE2N-mediated NF-κB activity downstream of multiple innate immune receptors in human THP-1 AML cells, with no effect on UBE2N-independent pathways[1].
UC-764864 (0-10 μM; 24-72 h) selectively suppresses viability and clonogenic potential of human AML cell lines and MDS cells in vitro, with no effect on healthy cord blood CD34+ cells[1].
UC-764864 (0.5-5 μM; 24-96 h) induces time- and dose-dependent cell death and apoptosis in human MOLM-13 AML cells in vitro[1].
UC-764864 (100 nM-10 μM; 72 h) exerts inhibitory effects on human MOLM-13 AML cell viability that depend on targeting the catalytic Cys87 residue of UBE2N, as UBE2NC87S-expressing cells are resistant to UC-764864[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human MOLM-13 AML cells
-
Concentration:0.5 μM; 1 μM; 2μM
-
Incubation Time:24 h
-
Result:Increased the proportion of apoptotic cells from ~15% to ~35% (P < 0.01) after 24-hour treatment with 2 μM.
化学情報
-
CAS 番号 278806-03-4
-
性状 Solid
-
分子量 322.42
-
分子式 C19H18N2OS
-
Color Light yellow to yellow
-
SMILES
O=C(C1=CC=C(CC)C=C1)/C=C/SC2=NC3=C(N2)C=CC(C)=C3
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
溶剤 & 溶解度
体外:
DMSO : 125 mg/mL (387.69 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
プロトコル
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
純度とドキュメンテーション
-
データシート (271 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
取扱説明書 (2659 KB)
参考文献
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.1015 mL | 15.5077 mL | 31.0154 mL | 77.5386 mL |
| 5 mM | 0.6203 mL | 3.1015 mL | 6.2031 mL | 15.5077 mL | |
| 10 mM | 0.3102 mL | 1.5508 mL | 3.1015 mL | 7.7539 mL | |
| 15 mM | 0.2068 mL | 1.0338 mL | 2.0677 mL | 5.1692 mL | |
| 20 mM | 0.1551 mL | 0.7754 mL | 1.5508 mL | 3.8769 mL | |
| 25 mM | 0.1241 mL | 0.6203 mL | 1.2406 mL | 3.1015 mL | |
| 30 mM | 0.1034 mL | 0.5169 mL | 1.0338 mL | 2.5846 mL | |
| 40 mM | 0.0775 mL | 0.3877 mL | 0.7754 mL | 1.9385 mL | |
| 50 mM | 0.0620 mL | 0.3102 mL | 0.6203 mL | 1.5508 mL | |
| 60 mM | 0.0517 mL | 0.2585 mL | 0.5169 mL | 1.2923 mL | |
| 80 mM | 0.0388 mL | 0.1938 mL | 0.3877 mL | 0.9692 mL | |
| 100 mM | 0.0310 mL | 0.1551 mL | 0.3102 mL | 0.7754 mL |